Zen Medical, LLC., a division of Sanomedics, Inc. (OTC: SIMH) announced today that it will be exhibiting at booth # 8 at Innovations in Behavioral Healthcare in Nashville, Tennessee, June 22-23 at the Hilton Downtown Nashville.
Innovations in Behavioral Healthcare is a new conference at the intersection of the treatment industry, the medical field and business management. With an emphasis on physical and mental health, Innovations in Behavioral Healthcare provides training on effective methods for treating substance abuse, best practices for treating mental health conditions, approaches for timely interventions, insights into revenue management and more. Attendees will come away with a greater knowledge of how to treat addiction and mental health conditions and how to run a thriving behavioral healthcare business.
Zen Medical will showcase ZenCharts™, its best-of-breed Electronic Health Records (EHR) that offer quick access to patient records from multiple locations, improving the ability to diagnose diseases and reduce medical errors. The EHR system not only improves patient care but also increases practice efficiencies such as enabling electronic prescriptions, increased accuracy in coding and billing and facilitating more reliable charting, all of which results in cost and time savings.
“The addiction treatment center market is heavily underserved market and with over 15,000 centers in the United States alone that can benefit from our solution, we look forward to showcasing ZenCharts™ to behavioral healthcare professionals at the conference,” said Keith Houlihan, President of Sanomedics.
About Sanomedics, Inc.
Sanomedics, Inc. (OTC: SIMH) is an international medical technology company focused on developing, manufacturing, and acquiring cutting-edge technology, products and services. The Company operates mainly through its subsidiary, Thermomedics, which is dedicated to engineering, marketing and selling the Caregiver TouchFree™ Infrared thermometer. The Caregiver non-contact thermometer is FDA-cleared in the United States for clinical use by medical professionals. The Caregiver provides an accurate and expedited temperature reading without direct contact between patient and medical professional. Sanomedics has established an extensive distribution network with several leading healthcare supply chain providers to increase adoption of the Caregiver device within the medical community worldwide.
Forward Looking Statements
Statements in this press release regarding Sanomedics that are not historical facts are forward- looking statements and are subject to risks and uncertainties that could cause actual future events or results to differ materially from such statements. Any such forward-looking statements, including, but not limited to, financial guidance are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not directly or exclusively relate to historical facts. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “projects,” “forecasts,” “predicts,” “potential,” or the negative of those terms, and similar expressions and comparable terminology. These include, but are not limited to, statements relating to future events or our future financial and operating results, plans, objectives, expectations and intentions. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these expectations may not be achieved. Forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to known and unknown risks, uncertainties and other factors outside of our control that could cause our actual results, performance or achievement to differ materially from those expressed or implied by these forward-looking statements.
These forward-looking statements represent our estimates and assumptions only as of the date of this release and, except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this release. Given these uncertainties, you should not place undue reliance on these forward-looking statements and should consider various factors, including the risks described, among other places, in our most recent Annual Report on Form 10-K and in our Quarterly Reports on Form 10-Q, as well as any amendments thereto, filed with the SEC.
Investor Contacts:
Phil Carlson / Elizabeth Barker
KCSA Strategic Communications
212-896-1233 / 212-896-1203
pcarlson@kcsa.com / ebarker@kcsa.com
Media Contacts:
Chloe Font / Andrew Herweg
KCSA Strategic Communications
212-896-1287 / 212-896-1273
cfont@kcsa.com / aherweg@kcsa.com
